Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial (vol 23, pg 117, 2023)-MedSci.cn

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial (vol 23, pg 117, 2023)

Wedemeyer, H; Schoneweis, K; Bogomolov, P

LANCET INFECTIOUS DISEASES, 2022; 22 (12): E348

科室
- - 订阅+
  - 更多科室
工具
服务